Dan Marshak

Biography

Daniel R. Marshak, Ph.D., is an experienced executive in the Life Sciences, Diagnostics, and Biopharmaceutical industries, leading high-technology, global businesses and R&D functions for more than twenty years. Currently, Dr. Marshak is a consultant to several biotechnology and life sciences companies, as well as financial firms, including Ferghana Partners Group and 5AM Ventures. He previously served as Senior Vice President & Chief Scientific Officer for PerkinElmer Inc. (NYSE:PKI) from 2006-2014. Prior to joining PerkinElmer, Dr. Marshak was Vice President and Chief Technology Officer, Biotechnology, for Cambrex Corporation (NYSE:CBM.) In that role, he helped build and manage the BioScience business unit through significant organic growth, including the first contract manufacturing of cell therapy products and other biologics. Dr. Marshak previously served as Senior Vice President and Chief Technology Officer for Osiris Therapeutics, Inc. where he led stem cell research and development of mesenchymal stem cell products from inception to clinical trials. He was previously Senior Staff Investigator at the Cold Spring Harbor Laboratory, directing a basic research lab 1986-1995. Dr. Marshak is the author of more than 100 scientific publications, and is an inventor on eight issued U.S. patents. He held an appointment as adjunct Associate Professor at the Johns Hopkins University School of Medicine, and previously taught graduate biochemistry as Assistant Professor at the State University of New York, Stony Brook. Dr. Marshak received his Bachelor of Arts degree in Biochemical Sciences from Harvard University, and holds a Ph.D. in Biochemistry & Cell Biology from The Rockefeller University in New York City. He did postdoctoral work in Pharmacology at the Howard Hughes Medical Institute in Vanderbilt University School of Medicine and was a Pharmacology Research Associate Training Fellow at the National Institute of Health.

Research Interest

BIOCHEMISTRY, CELL CIOLOGY, PHARMACOLOGY